Abstract
Thrombosis and the complicating emboli that can result are important causes of illness and death. Thrombosis is of greater overall clinical importance in terms of morbidity and mortality than all of the hemorrhagic disorders combined. Agents such as heparin, low-molecular weight heparin, warfarin, aspirin, ticlopidine, clopidogrel, and tirofiban are used to prevent venous or arterial thrombosis. Patients taking these antithrombotic agents may be at risk for excessive bleeding after invasive dental procedures. The current antithrombotic agents used in medicine are reviewed, and the dental management of patients taking these agents is discussed.
MeSH terms
-
Anticoagulants / therapeutic use
-
Aspirin / therapeutic use
-
Blood Coagulation Tests
-
Clopidogrel
-
Dental Care*
-
Drug Interactions
-
Embolism / prevention & control
-
Fibrinolytic Agents / therapeutic use*
-
Hemostasis / physiology
-
Heparin / therapeutic use
-
Heparin, Low-Molecular-Weight / therapeutic use
-
Humans
-
Oral Hemorrhage / prevention & control
-
Platelet Aggregation Inhibitors / therapeutic use
-
Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors
-
Thrombosis / prevention & control
-
Ticlopidine / analogs & derivatives
-
Ticlopidine / therapeutic use
-
Tirofiban
-
Tyrosine / analogs & derivatives*
-
Tyrosine / therapeutic use
-
Venous Thrombosis / prevention & control
-
Warfarin / therapeutic use
Substances
-
Anticoagulants
-
Fibrinolytic Agents
-
Heparin, Low-Molecular-Weight
-
Platelet Aggregation Inhibitors
-
Platelet Glycoprotein GPIIb-IIIa Complex
-
Tyrosine
-
Warfarin
-
Heparin
-
Clopidogrel
-
Tirofiban
-
Ticlopidine
-
Aspirin